Cargando…

Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada

PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prio...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Christine A., Lee, Grace, Liu, Zhihui A., Liu, Fei-Fei, Fyles, Anthony, Han, Kathy, Barry, Aisling, Croke, Jennifer, Rodin, Danielle, Helou, Joelle, Hahn, Ezra, Isfahanian, Naghmeh, DeRocchis, Jane, Lofgren, Susanne, Purdie, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303606/
https://www.ncbi.nlm.nih.gov/pubmed/32775788
http://dx.doi.org/10.1016/j.adro.2020.06.002
_version_ 1783548094553522176
author Koch, Christine A.
Lee, Grace
Liu, Zhihui A.
Liu, Fei-Fei
Fyles, Anthony
Han, Kathy
Barry, Aisling
Croke, Jennifer
Rodin, Danielle
Helou, Joelle
Hahn, Ezra
Isfahanian, Naghmeh
DeRocchis, Jane
Lofgren, Susanne
Purdie, Thomas G.
author_facet Koch, Christine A.
Lee, Grace
Liu, Zhihui A.
Liu, Fei-Fei
Fyles, Anthony
Han, Kathy
Barry, Aisling
Croke, Jennifer
Rodin, Danielle
Helou, Joelle
Hahn, Ezra
Isfahanian, Naghmeh
DeRocchis, Jane
Lofgren, Susanne
Purdie, Thomas G.
author_sort Koch, Christine A.
collection PubMed
description PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prioritization of radiation therapy by oncologic risk and omission or deferral of radiation therapy for lower risk cases. Timely adoption of these measures reduces COVID-19 risk to both patients and health care workers and preserves resources. Herein, we present our early response and adaptation of breast radiation therapy utilization during the COVID-19 pandemic at a large academic cancer center in Canada. METHODS AND MATERIALS: A state of emergency was announced in Ontario on March 17, 2020, owing to the COVID-19 pandemic. Emergency guidelines were instituted. To examine our response, the number of weekly breast radiation therapy starts, type of breast radiation therapy, and patient age were compared from March 1 to April 30, 2020 to the same period in 2019. RESULTS: After the declaration of emergency in Ontario, there was a decrease of 39% in radiation therapy starts in 2020 compared with 2019 (79 vs 129, P < .001). There was a relative increase in the proportion of patients receiving regional nodal irradiation (RNI) in 2020 compared with 2019 (46% vs 29%, respectively), with the introduction of hypofractionated RNI in 2020 (27 of 54 cases, 50%). A smaller proportion of patients starting radiation therapy were aged >50 years in 2020, 66% (78 of 118) versus 83% (132 of 160) in 2019, P = .0027. CONCLUSIONS: A significant reduction in breast radiation therapy starts was noted during the early response to the COVID-19 pandemic, with prioritization of radiation therapy to patients associated with higher oncologic risk requiring RNI. A quick response to a health care crisis is critical and is of particular importance for higher volume cancer sites where the potential effect on resources is greater.
format Online
Article
Text
id pubmed-7303606
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73036062020-06-19 Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada Koch, Christine A. Lee, Grace Liu, Zhihui A. Liu, Fei-Fei Fyles, Anthony Han, Kathy Barry, Aisling Croke, Jennifer Rodin, Danielle Helou, Joelle Hahn, Ezra Isfahanian, Naghmeh DeRocchis, Jane Lofgren, Susanne Purdie, Thomas G. Adv Radiat Oncol Practical considerations during COVID19 – Outcomes, education, and intervention PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prioritization of radiation therapy by oncologic risk and omission or deferral of radiation therapy for lower risk cases. Timely adoption of these measures reduces COVID-19 risk to both patients and health care workers and preserves resources. Herein, we present our early response and adaptation of breast radiation therapy utilization during the COVID-19 pandemic at a large academic cancer center in Canada. METHODS AND MATERIALS: A state of emergency was announced in Ontario on March 17, 2020, owing to the COVID-19 pandemic. Emergency guidelines were instituted. To examine our response, the number of weekly breast radiation therapy starts, type of breast radiation therapy, and patient age were compared from March 1 to April 30, 2020 to the same period in 2019. RESULTS: After the declaration of emergency in Ontario, there was a decrease of 39% in radiation therapy starts in 2020 compared with 2019 (79 vs 129, P < .001). There was a relative increase in the proportion of patients receiving regional nodal irradiation (RNI) in 2020 compared with 2019 (46% vs 29%, respectively), with the introduction of hypofractionated RNI in 2020 (27 of 54 cases, 50%). A smaller proportion of patients starting radiation therapy were aged >50 years in 2020, 66% (78 of 118) versus 83% (132 of 160) in 2019, P = .0027. CONCLUSIONS: A significant reduction in breast radiation therapy starts was noted during the early response to the COVID-19 pandemic, with prioritization of radiation therapy to patients associated with higher oncologic risk requiring RNI. A quick response to a health care crisis is critical and is of particular importance for higher volume cancer sites where the potential effect on resources is greater. Elsevier 2020-06-19 /pmc/articles/PMC7303606/ /pubmed/32775788 http://dx.doi.org/10.1016/j.adro.2020.06.002 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Practical considerations during COVID19 – Outcomes, education, and intervention
Koch, Christine A.
Lee, Grace
Liu, Zhihui A.
Liu, Fei-Fei
Fyles, Anthony
Han, Kathy
Barry, Aisling
Croke, Jennifer
Rodin, Danielle
Helou, Joelle
Hahn, Ezra
Isfahanian, Naghmeh
DeRocchis, Jane
Lofgren, Susanne
Purdie, Thomas G.
Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
title Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
title_full Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
title_fullStr Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
title_full_unstemmed Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
title_short Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
title_sort rapid adaptation of breast radiation therapy use during the coronavirus disease 2019 pandemic at a large academic cancer center in canada
topic Practical considerations during COVID19 – Outcomes, education, and intervention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303606/
https://www.ncbi.nlm.nih.gov/pubmed/32775788
http://dx.doi.org/10.1016/j.adro.2020.06.002
work_keys_str_mv AT kochchristinea rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT leegrace rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT liuzhihuia rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT liufeifei rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT fylesanthony rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT hankathy rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT barryaisling rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT crokejennifer rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT rodindanielle rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT heloujoelle rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT hahnezra rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT isfahaniannaghmeh rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT derocchisjane rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT lofgrensusanne rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada
AT purdiethomasg rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada